# SCP: Computerized Behavioral Therapy Device For Anxiety Disorders

- Device class: 2; regulation: 21 CFR 882.5801; FDA's rule: 510(k) required
- FDA decisions: 1
- 510(k) review time 2021–2025: median 267 days (middle half 267–267)
- Recalls: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026; MAUDE to Sep 30, 2026

## Decisions per year (last 10)
- 2024: 1

## Most-cited predicates

Source page: https://510kreport.com/product-code/SCP
Data by year (CSV): https://510kreport.com/product-code/SCP.csv